-

Oxford Finance Closes $50 Million Credit Facility with Mainstay Medical

Mainstay Medical is focused on commercializing an implantable neurostimulation system for the treatment of chronic low back pain

ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $50 million senior secured term loan with Mainstay Medical Holdings plc (“Mainstay” or “the Company”), a medical device company focused on commercializing an innovative implantable restorative neurostimulation system, ReActiv8®, for the treatment of disabling mechanical chronic low back pain (“CLBP”).

ReActiv8 is an active implantable medical device that stimulates nerves responsible for activating a key muscle involved in stabilizing the lower back. ReActiv8 is designed to provide therapy for people whose lives are significantly impacted by intractable, mechanical CLBP. Contraction of the muscle can lead to restoration of control over time, allowing the back to recover from CLBP.

“Mainstay is preparing to launch the ReActiv8 device in the US to address the large population of mechanical CLBP patients who have limited treatment options,” said Christopher A. Herr, senior managing director at Oxford Finance. “Oxford is proud to support a Company using a novel method to treat an underserved medical issue which has the potential to help millions of people who suffer from chronic back pain.”

About Oxford Finance LLC
Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $6 billion in loans, with lines of credit ranging from $5 million to $150 million. Oxford is headquartered in Alexandria, Va., with additional offices in San Diego, Calif.; Palo Alto, Calif.; and the greater Boston and New York City areas. For more information, visit https://oxfordfinance.com/.

Contacts

Selma Bašić
Oxford Finance LLC
703-519-4900 Tel
media@oxfordfinance.com

Oxford Finance LLC


Release Summary
Oxford Finance Closes $50 Million Credit Facility with Mainstay Medical
Release Versions

Contacts

Selma Bašić
Oxford Finance LLC
703-519-4900 Tel
media@oxfordfinance.com

Social Media Profiles
More News From Oxford Finance LLC

Oxford Finance Strengthens ABL Platform with Appointment of Brock Johnson to Lead Underwriting

ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford” or the “Company”), a leading specialty finance firm, is pleased to announce the appointment of Brock Johnson to lead Underwriting for its newly created Asset Based Lending (“ABL”) division. In this role, Mr. Johnson will lead the firm’s ABL credit strategy, overseeing deal structuring, credit analysis, and risk management. This key addition strengthens Oxford’s growing ABL platform and reinforces the Company’s commitment to deliveri...

Oxford Finance Appoints Nick McDearis to Lead ABL Originations, Expands into Traditional ABL Market

ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford” or the “Company”), a leading specialty finance firm, is pleased to announce the appointment of Nick McDearis to lead Asset-Based Lending (ABL) Originations. This strategic hire marks a significant milestone as Oxford enters the traditional ABL market. Nick McDearis brings nearly 20 years of experience in the ABL industry and a proven track record of success in originating and structuring complex financing solutions. His expertise an...

Oxford Finance's Real Estate and ABL Team Achieves Over $715 Million in New Loan Volume in First Half of 2025

ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford”), a leading specialty finance firm, is pleased to announce its Healthcare Real Estate and Asset-Based Lending (ABL) team closed 10 transactions with new loan commitments of over $715 million during the first half of 2025. This achievement underscores Oxford's commitment to providing innovative and flexible financing solutions to the healthcare industry. The team’s success in the first half of 2025 highlights its ability to adapt to...
Back to Newsroom